Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
advertising, advisory, aforesaid, al, alfa, appellate, bench, Book, Bristol, buying, committee, conducted, constitutionality, Department, Deva, director, docetaxel, dosing, enterprise, epoetin, Fast, FL, flat, Foundation, free, French, hemoglobin, IPR, Irish, JNDA, Labor, lieu, MA, mantle, MCL, MEDALIST, Medicaid, Merck, neoplasm, network, nonrefundable, Norwegian, percent, Prescribing, prostate, radiographic, receipt, restraining, speech, statutory, streamlining, upheld, upholding, USPTO, vote, voted, voting
Removed:
achievement, amend, answer, awarding, banc, Central, certiorari, consist, criteria, declared, declining, en, fibrotic, hedging, improvement, infringed, Kite, LIBOR, negotiate, occurred, permission, placebo, POETYK, prejudgment, PSO, rehearing, rejected, remand, removed, reversed, SKI, spread, standard, sustained, willfully, writ, Yescarta
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view